BIOIMAGENE AND SCIMAGIX MERGE TO PROVIDE COMPREHENSIVE IMAGE ANALYSIS AND INFORMATICS SOLUTION

San Jose, California, November 10, 2004

BioImagene and Scimagix are pleased to announce their merger. The combination of BioImagene's core competency in image analysis with Scimagix's image management and data mining technology address major pain-points in the discovery and histo-pathology markets. Together, they will provide complete, integrated solutions for gels, cells and tissues, from initial analysis to data mining and post-hoc analysis. This comprehensive, web-enabled suite of products is a major step toward the companies' joint goal of enabling digital discovery and histo-pathology.


Full Story...


BIOIMAGENE SECURED $ 4.2 MILLION IN SERIES B FINANCING LED BY TUPUTELE VENTURES AND AUTHOSIS VENTURES

San Jose, California, October 12, 2004

BioImagene, the innovative provider of digital pathology solutions, announced today the close of its $4.2 million Series B financing led by Tuputele Ventures, Authosis, Inc. and ICCP Ventures. BioImagene will use these funds to launch its product globally and to expand its sales and marketing efforts in North America, Europe and Asia Pacific.


Full Story...


BIOIMAGENE ANNOUNCES US LABS AS ITS FIRST STRATEGIC CUSTOMER TO LAUNCH AN INNOVATIVE DIGITAL PATHOLOGY SOLUTION

San Jose, California, September 27, 2004

US LABS offers its Virtual Image™ digital pathology solution, built on iHARNESS™, to all customers within its network.
BioImagene, the innovative provider of digital pathology solutions, announced that US LABS, a national, anatomic pathology reference laboratory devoted to comprehensive, high quality, rapid response cancer testing, has selected its iHARNESS™-powered image analysis solution to offer Virtual Image, a unique service, to its network of pathologists and pathology centers.


Full Story...